Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study

Overview of attention for article published in BMC Neurology, September 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 tweeters

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 73 Mendeley

Summary Twitter Dimensions citations

So far, Dimensions has found 27 publications that cite this research output.

27

The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.

The facioscapulohumeral muscular dystrophy – health index: Italian validation of a disease-specific measure of symptomatic burden

Article in Disability and Rehabilitation (May 2023)

268th ENMC workshop - Genetic diagnosis, clinical classification, outcome measures, and biomarkers in Facioscapulohumeral Muscular Dystrophy (FSHD): Relevance for clinical trials

Article in Neuromuscular Disorders (April 2023)

Patient engagement in drug development: configuring a new resource for generating innovation

Article in Critical Public Health (March 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.